SCHEMBL1102465

SCHEMBL1102465

CC(C)c1ccc2c(c1)C(C)(C)c1cc(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccncc45)cc3)ccc1-2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 3/20 0.36
PDK2 Q15119 4/20 0.34
DHODH Q02127 1/20 0.32
CYP17A1 P05093 3/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
MAPK14 Q16539 1/20 0.32
METAP2 P50579 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
ROCK2 O75116 1/20 0.32
PIK3CD O00329 1/20 0.32
KDR P35968 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102456 0.97 DGAT2 (0.36) DGAT2PDK2DHODHCYP17A1AKR1C3
SCHEMBL1102592 0.97 PDK2 (0.35) DGAT2PDK2DHODHAKR1C3AKR1C2
SCHEMBL1102473 0.94 DGAT2 (0.37) DGAT2PDK2DHODHAKR1C3AKR1C2
SCHEMBL1102678 0.91 PDK2 (0.39) DGAT2PDK2DHODHPIK3CDALOX5
SCHEMBL1102686 0.90 PDK2 (0.38) DGAT2PDK2DHODHPIK3CDALOX5
SCHEMBL1102515 0.89 PDK2 (0.36) DGAT2PDK2DHODHKDRTDP1
SCHEMBL1102542 0.89 PDK2 (0.39) DGAT2PDK2DHODHPIK3CDALOX5
SCHEMBL1102529 0.88 CYP17A1 (0.36) DGAT2PDK2CYP17A1AKR1C3AKR1C2
SCHEMBL1102570 0.88 KDR (0.36) DGAT2PDK2DHODHAKR1C3AKR1C2
SCHEMBL1102799 0.88 PDK2 (0.42) DGAT2PDK2PIK3CDALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 DGAT2 778/4885PDK2 1930/4885DHODH 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.